Canopy Immuno-Therapeutics

Immunotherapeutic Approach for Autoimmunity and Life-threatening Allergies

Active A Startup Haifa Founded 2020-01

Website ↗ LinkedIn

Canopy is a pre-clinical stage biotech developing a new class of biologics that will allow the elimination of antigen-specific immunity, providing non-immunosuppressive, potentially curing treatments to many dozens of autoimmune, allergic, and other antibody-mediated conditions using its proprietary Reverse-Immunization platform.